Schroder Investment Management Group Pacira Bio Sciences, Inc. Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.5 - $31.51 $297,865 - $368,068	11,681 Added 1.93%	616,832 $17.6 Million
Q1 2024 May 14, 2024	SELL	$27.7 - $35.48 $458,656 - $587,477	-16,558 Reduced 2.66%	605,151 $17.7 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $1.21 Million - $1.58 Million	-45,919 Reduced 6.88%	621,709 $21 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $5.26 Million - $6.87 Million	-171,307 Reduced 20.42%	667,628 $20.5 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $5.75 Million - $7.56 Million	159,258 Added 23.43%	838,935 $33.6 Million
Q1 2023 May 11, 2023	SELL	$35.53 - $43.38 $61,040 - $74,526	-1,718 Reduced 0.25%	679,677 $27.7 Million
Q4 2022 Feb 10, 2023	SELL	$38.19 - $57.45 $73,783 - $110,993	-1,932 Reduced 0.28%	681,395 $26.3 Million
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $5.47 Million - $6.29 Million	106,797 Added 18.52%	683,327 $36.3 Million
Q2 2022 Aug 11, 2022	SELL	$51.49 - $81.64 $6.15 Million - $9.75 Million	-119,383 Reduced 17.15%	576,530 $33.6 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $3.11 Million - $3.96 Million	51,751 Added 8.03%	695,913 $52.7 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $7.55 Million - $9.8 Million	157,487 Added 32.36%	644,162 $38.8 Million
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $4.03 Million - $4.52 Million	-73,711 Reduced 13.15%	486,675 $27.3 Million
Q2 2021 Aug 13, 2021	SELL	$59.18 - $69.99 $329,099 - $389,214	-5,561 Reduced 0.98%	560,386 $34 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $3.36 Million - $4.46 Million	56,617 Added 11.12%	565,947 $39.7 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $4.02 Million - $5.27 Million	-79,590 Reduced 13.51%	509,330 $30.5 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $4.71 Million - $5.71 Million	-90,614 Reduced 13.33%	588,920 $35.1 Million
Q2 2020 Aug 13, 2020	SELL	$30.8 - $52.47 $4.3 Million - $7.33 Million	-139,634 Reduced 17.05%	679,534 $35.7 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $2.58 Million - $4.61 Million	-90,840 Reduced 9.98%	819,168 $26.2 Million
Q4 2019 Feb 11, 2020	BUY	$36.31 - $46.83 $4.3 Million - $5.54 Million	118,291 Added 14.94%	910,008 $41.2 Million
Q3 2019 Nov 12, 2019	BUY	$35.66 - $44.99 $2.11 Million - $2.67 Million	59,244 Added 8.09%	791,717 $31.7 Million
Q2 2019 Aug 08, 2019	BUY	$36.57 - $47.97 $327,484 - $429,571	8,955 Added 1.24%	732,473 $31.9 Million
Q1 2019 May 14, 2019	SELL	$36.47 - $42.17 $9.4 Million - $10.9 Million	-257,617 Reduced 26.26%	723,518 $27.5 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $123,145 - $155,488	2,981 Added 0.3%	981,135 $42.2 Million
Q3 2018 Nov 13, 2018	SELL	$32.85 - $52.0 $9.1 Million - $14.4 Million	-276,876 Reduced 22.06%	978,154 $48.1 Million
Q2 2018 Aug 24, 2018	BUY	$27.5 - $39.8 $20.2 Million - $29.2 Million	733,651 Added 140.71%	1,255,030 $39 Million
Q2 2018 Aug 13, 2018	SELL	$27.5 - $39.8 $19.4 Million - $28 Million	-704,428 Reduced 57.47%	521,379 $18 Million
Q1 2018 May 11, 2018	BUY	$29.98 - $46.35 $7.36 Million - $11.4 Million	245,601 Added 25.06%	1,225,807 $38.2 Million
Q4 2017 Feb 09, 2018	BUY	$31.85 - $46.95 $1.04 Million - $1.54 Million	32,801 Added 3.46%	980,206 $44.7 Million
Q3 2017 Nov 09, 2017	BUY	$35.7 - $39.5 $33.8 Million - $37.4 Million	947,405	947,405 $36.7 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account